jueves, 3 de septiembre de 2020

FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development | Orphanet Journal of Rare Diseases | Full Text

FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development | Orphanet Journal of Rare Diseases | Full Text



The Office of Orphan Products Development (OOPD) of the United States (U.S.) Food and Drug Administration (FDA) has awarded over 700 grants to conduct clinical trials of medicals products for rare diseases sin...
Authors:Kathleen L. Miller, Christine Mueller, Gumei Liu, Katherine I. Miller Needleman and Janet Maynard
Citation:Orphanet Journal of Rare Diseases 2020 15:234
Content type:Research
 
Published on: 

No hay comentarios:

Publicar un comentario